miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
about
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerRegulation of Mutant p53 Protein ExpressionDysregulation of non-coding RNAs in gastric cancerHelicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditionsThe functional sites of miRNAs and lncRNAs in gastric carcinogenesisTumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.Epigenetics: an emerging player in gastric cancerGenome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersThe expression pattern of microRNAs in granulosa cells of subordinate and dominant follicles during the early luteal phase of the bovine estrous cycleTBHP-induced oxidative stress alters microRNAs expression in mouse testisMicroribonucleic acids and gastric cancer.Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway.Dynamical behaviors of Rb-E2F pathway including negative feedback loops involving miR449.MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells.MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met.Expression and clinical significance of the microRNA-200 family in gastric cancer.Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.Association between promoter polymorphisms of matrix metalloproteinase-1 and risk of gastric cancermiR-221 and miR-222 Simultaneously Target RECK and Regulate Growth and Invasion of Gastric Cancer Cells.The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.How interacting pathways are regulated by miRNAs in breast cancer subtypes.Hsa-miR-449a genetic variant is associated with risk of gastric cancer in a Chinese population.Inhibiting microRNA-449 Attenuates Cisplatin-Induced Injury in NRK-52E Cells Possibly via Regulating the SIRT1/P53/BAX PathwayMicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cellsTargeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.MiR-449a promotes breast cancer progression by targeting CRIP2.miRNA: The nemesis of gastric cancer (Review).MicroRNAs and lncRNAs in senescence: A re-view.Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium.Identification of microRNAs dysregulated in cellular senescence driven by endogenous genotoxic stress.The role of microRNAs in cancers of the upper gastrointestinal tract.Regulation of the unfolded protein response by microRNAs.Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigenAdvances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma.
P2860
Q26744362-69F02F54-B13E-4040-BC7A-133AB2AD70DEQ26770579-29461133-9D79-4801-81D1-D16694E9E3A2Q26780293-CE0283EE-D3B2-4C46-8655-795614189C99Q26782813-E0779EB5-08BC-4E48-A5CA-552424C3F9E3Q27026837-4A1BD83A-E1B6-41BE-BBAA-C5E2A85A8DBBQ30543779-F778ECF0-D509-459B-925F-97F7F6D48CA7Q33718259-07AC56A9-E09A-4C09-877D-C8C047FAE868Q33917664-D7C64BBC-8FF2-4A61-9CBD-EF0D963DB2F8Q34142608-5A6D2628-B078-463B-A3FE-60884BD02300Q34226453-ACC012B7-CD86-4C44-8DB9-CFED0D7D5F97Q34240588-75B86BB4-E341-451E-84B6-60EC0196E16CQ34268565-98E03209-BC20-4AEF-B675-178237113C29Q34273664-4B586B6C-2A3A-43C2-919B-4C7B0BF36580Q34426867-BDB5BDD9-FDEC-401F-B8F6-852242337AA3Q34685821-236FA3D0-1EEF-4584-86FE-702360ADAD82Q34704989-978DC742-268A-4049-A079-1638FC18FB06Q34755653-E1AF2E61-6051-474B-9CEC-50470F7463BDQ35742259-5412D7D9-7E13-4EB8-80CB-C1D73C1C549FQ35961920-656C23D7-91DF-41BC-8D3B-486AA9AEB32CQ36072407-B7013DA6-345F-4208-8F9C-518ED9043247Q36078388-72C9F511-EC6B-4502-B91C-34DEE70CB0EAQ36158807-31CEA138-6377-4A5E-8423-BBFE73F517F4Q36250644-555AD6B8-6D31-4334-945F-9199EA56E5D7Q36276533-E4F8D804-46DF-43DB-95D8-EA7F15924801Q36375480-8F518C28-8605-4E9B-846D-A476DADF37EFQ36688098-4024FECE-59C5-4933-8CC6-DC9EFAE939E1Q36959452-830FB87C-AE86-4B03-9CDC-D5186DB38A74Q36992190-444893DA-0706-4455-AE45-493312AC91F1Q37041036-B246F514-1948-46E7-90F3-1A1FA70290C0Q37109753-13F1F986-638C-4ADF-8582-0D958AAC9FEEQ37109894-5F4D7E4E-7D28-46F5-B6BC-F2F8FB244908Q37211784-77C2D781-78D1-4B96-B800-D0BDBC2E9C53Q37225031-847E9C04-AC55-4C87-AE6C-73470E2B42B0Q37231719-367AA1DC-29E6-449D-91A1-5B98FAA0D6D8Q37298895-4AFBC540-7659-4D13-A5E7-85E51AB45E89Q37374880-45E8EE51-B263-441C-ABA3-CFA96DFF0C8BQ37423378-4022DCB7-B9B7-432B-98F5-9D1ECE631680Q37437986-6D25B5D7-4AFC-4F06-9565-A0B2981D8C06Q37537123-558F61D1-041E-45EC-B03F-A5EB8DA8C21FQ37735611-8851D163-7996-469E-A273-8CCB24046457
P2860
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@ast
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@en
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@en-gb
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@nl
type
label
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@ast
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@en
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@en-gb
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@nl
prefLabel
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@ast
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@en
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@en-gb
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
@en
P2093
Birgitte Federspiel
Christoffer Hother
Ewa Futoma-Kazmierczak
Linda Bardram
Tony Bou Kheir
P2860
P2888
P3181
P356
10.1186/1476-4598-10-29
P407
P577
2011-01-01T00:00:00Z
P5875
P6179
1000045303